[1]
“IMMUNOGENICITY OF A HETEROLOGOUS INACTIVATED AND mRNA COVID-19 COMBINATION VACCINE REGIMEN: heterologous inactivated and mRNA COVID-19 vaccine regimen”, SEATROPH, vol. 54, no. 4, pp. 167–181, Jul. 2023, Accessed: Apr. 29, 2026. [Online]. Available: https://journal.seameotropmednetwork.org/index.php/jtropmed/article/view/864